CTY
Ticker
City Therapeutics, Inc.
CTY · Healthcare · City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineerin…City Therapeutics, Inc. (CTY), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 2 purchases and 0 sales. Filers took a median of 0 days from execution to disclosure, and the most recent trade was executed Oct 19 and filed Oct 19. The most active filer was ARCH Venture Partners XII, LLC with 1 filing. Data as of Nov 8 2026.
Add to watchlistFilings, ttm
2
2 buys · 0 sells
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$6.1M
estimated for Congress, as filed for insiders
Median delay
0d
execution to disclosure
Last traded
Oct 19
Filed Oct 19
ADViAverage daily dollar volume
$30.2M
market data
Share price · 12M
$20.77 (-7.3%)
Adjusted for splits and dividends.
Volume by month
Buys $6.1M
Sells $0
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed · past 24 months
AL
ARCH Venture Partners XII, LLC
10% owner
1 filing · 1 buy, 0 sales
RNRecent filings
ARCH Venture Partners XII, LLCPURCHASE
10% owner
$3.1M170,000 sh × $18.00
Exec Oct 19
Filed Oct 19 · 5:38 PM ET Robert NelsenPURCHASE Director $3.1M
170,000 sh × $18.00
Exec Oct 19
Filed Oct 19 · 5:37 PM ET